Current status and future potential of transdermal drug delivery

Nature Reviews Drug Discovery

Volumn 3, Issue 2, 2004, Pages 115-124

  Prausnitz, Mark R ^a   Mitragotri, Samir ^b   Langer, Robert ^c  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b University of California at Santa Barbara   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NONYL 1,3 DIOXOLANE; ADRENALIN; ALCOHOL; CLONIDINE; DIMETHYL SULFOXIDE; ESCLIM; ESTER DERIVATIVE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORELGESTROMIN; FATTY ACID; FENTANYL; GLYCERYL TRINITRATE; IONTOCAINE; LAUROCAPRAM; LIDOCAINE; LIMONENE; NICOTINE; OLEIC ACID; OXYBUTYNIN; PENETRATION ENHANCING AGENT; SCOPOLAMINE; SOLVENT; SURFACTANT; TERPENE; TESTODERM TTS; TESTOSTERONE; UNCLASSIFIED DRUG;

ANGINA PECTORIS; BIRTH CONTROL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RESEARCH; ELECTROPORATION; EPIDERMIS; HORMONE SUBSTITUTION; HUMAN; HYDROPHILICITY; HYPERTENSION; HYPOGONADISM; INTERMETHOD COMPARISON; IONTOPHORESIS; JET INJECTION; LIPOPHILICITY; MATHEMATICAL MODEL; MEDICAL TECHNOLOGY; MOTION SICKNESS; NEEDLE; OVERACTIVE BLADDER; PAIN; POSTHERPETIC NEURALGIA; PREDICTION; PRIORITY JOURNAL; REVIEW; SKIN IRRITATION; SKIN PERMEABILITY; STRATUM CORNEUM; TRANSDERMAL PATCH; ULTRASOUND; UNITED STATES;

EID: 1242308254     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1304     Document Type: Review

References (119)

1. Rein, H. Experimental electroendosmotic studies on living human skin. Z. Biol. 81, 124- (1924).
2. Blank, I. H. Penetration of low-molecular weight alcohols into skin. I. Effect of concentration of alcohol and type of vehicle. J. Invest. Dermatol. 43, 415-420 (1964).
3. Scheuplein, R. J. Mechanism of percutaneous adsorption I. Routes of penetration and the influence of solubility. J. Invest. Dermatol. 45, 334-345 (1965).
4. Scheupein, R. J. & Blank, I. H. Permeability of the skin. Physiol. Rev. 51, 702-747 (1971).
5. Michaels, A. S., Chandrasekaran, S. K. & Shaw, J. E. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE J. 21, 985-996 (1975).
6. Sifton, D. W. (ed.) Physicians' Desk Reference (Thomson PDR, Montvale, 2003).
7. Cramer, M. P. & Saks, S. R. Translating safety, efficacy and compliance into economic value for controlled release dosage forms. Pharmacoeconomics 5, 482-504 (1994).
8. Henningfield, J. E. Nicotine medications for smoking cessation. N. Engl. J. Med. 333, 1196-1203 (1995).
9. Zaffaroni, A. Overview and evolution of therapeutic systems. Ann. NY Acad. Sci. 618, 405-421 (1991).
10. Wertz, P. W. & Downing, D. T. in Transdermal Drug Delivery: Developmental Issues and Research Intiatives (eds Hadgraft, J. & Guy, R. H.) 1-17 (Marcel Dekker, 1989).
11. Champion, R. H., Burton, J. L., Burns, D. A. & Breathnach, S. M. (eds). Textbook of Dermatology (Blackwell Science, London, 1998).
12. Elias, P. M. & Feingold, K. R. Coordinate regulation of epidermal differentiation and barrier homeostasis. Skin Pharmacol. Appl. Skin Physiol. 14 (Suppl. 1), 28-34 (2001).
13. Marrink, S. J. & Berendsen, J. C. Permeation process of small molecules across lipid membranes studied by molecular dynamics simulations. J. Phys. Chem. 100, 16729-16738 (1996).
14. Peck, K. D., Ghanem, A. H. & Higuchi, W. I. Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane. Pharm. Res. 11, 1306-1314 (1994).
15. Mitragotri, S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J. Control. Release 86, 69-92 (2003).
16. Fiserova-Bergerova, V., Pierce, J. T. & Droz, P. O. Dermal absoprtion potential of industrial chemicals: criteria for skin notation. Am. J. Ind. Med. 17, 617-635 (1990).
17. McKone, T. E. & Howard, R. A. Estimating dermal uptake of non-ionic organic chemicals from water and soil: I. Unified fugacity-based models for risk assessment. Risk Analysis 12, 543-557 (1992).
18. Potts, R. O. & Guy, R. H. Predicting skin permeability. Pharm. Res. 9, 663-669 (1992).
19. Moss, G. P., Dearden, J. C., Patel, H. & Cronin, M. T. D. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol. In Vitro 16, 299-317 (2002).
20. Anderson, B. D. & Raykar, P. V. Solute structure-permeability relationships in human stratum corneum. J. Invest. Dermatol. 93, 280-286 (1989).
21. Cleek, R. L. & Bunge, A. L. A new method for estiamting dermal absorption from chemical exposure, 1. General approach. Pharm. Res. 10, 497-506 (1993).
22. Abraham, M. H., Martins, F. & Mitchell, R. C. Algorithms for skin permeability using hydrogen bond descriptors: the problem of steroids. J. Pharm. Pharmac. 49, 858-865 (1997).
23. Buchwald, P. & Bodor, N. A simple, predictive, structure-based skin permeability model. J. Pharm. Pharmacol. 53, 1087-1098 (2001).
24. Barrat, M. D. Quantitative structure-activity relationships for skin permeability. Toxicol. In Vitro 9, 27-37 (1995).
25. Pugh, W. J., Hadgraft, J. & Roberts, M. S. in Dermal Absorption and Toxicity Assessment (eds Roberts, M. S. & Walters, K.) 245-268 (Marcek Dekker, New York, 1998).
26. Lim, C. W., Fujiwara, S., Yamashita, F. & Hashida, M. Prediction of human skin permeability using a combination of molecular orbital calculations and artificial neural network. Biol. Pharm. Bull. 25, 361-366 (2002).
27. Frasch, H. F. A Random-walk model for skin permeation. Risk. Anal. 22, 265-276 (2002).
28. Kasting, G. B., Smith, R. L. & Cooper, E. R. Effect of lipid solubility and molecular size on percutaneous absorption. Pharmacol. Skin 1, 138-153 (1987).
29. French, E., Potton, C. & Walters, K. in Pharmaceutical Skin Penetration Enhnacement (eds Walters, K. & Hadgraft, J.) 113-144 (Marcel Dekker, New York, 1993).
30. Kanikkannan, N., Kanimalla, K., Lamba, S. S. & Singh, M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem. 7, 593-608 (2000).
31. Lashmar, U. T., Hadgraft, J. & Thomas, N. Topical application of penetration enhancers to the skin of nude mice: a histophatholgical study. J. Pharm. Pharmacol. 41, 118-122 (1989).
32. Takanashi, Y., Higashiyama, K., Komiya, H., Takayama, K. & Nagai, T. Thiomenthol derivatives as novel percutaneous absorption enhancers. Drug Dev. Ind. Pharm. 25, 89-94 (1999).
33. Akimoto, T. & Nagase, Y. Novel transdermal drug penetration enhancer: synthesis and enhancing effect of alkyldisiloxane comounds containign glucopyranosyl group. J. Control. Rel. 88, 243-252 (2003).
34. 1 SEPA gel for the treatment of erectile dysfunction. J. Urol. 162, 726-730 (1999).
35. Williams, A. C. & Barry, B. W. Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 9, 305-353 (1992).
36. Finin, B. C. & Morgan, T. M. Transdermal penetration enhancers: applications, limitations, and potential. J. Pharm. Sci. 88, 955-958 (1999).
37. Ongpipattnakul, B., Burnette, R. R., Potts, R. O. & Francoeur, M. L. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 8, 350-354 (1991).
38. Cevc, G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 13, 257-388 (1996).
39. Karande, P., Jain, A. & Mitragotri, S. Discovery of transdermal penetration enhancers by high-throughput screening. Nature Biotechnol. 4 Jan 2004 (doi:10.1038/nbt928).
40. Costello, C. T. & Jeske, A. H. Iontophoresis: applications in transdermal medication delivery. Phys. Ther. 75, 554-563 (1995).
41. Warwick, W. J. et al. Evaluation of a cystic fibrosis screening system incorporating a miniature sweat stimulator and disposable chloride sensor. Clin. Chem. 32, 850-853 (1986).
42. Hölzle, E. & Alberti, N. Long-term efficacy and side effects of tap water iontophoresis of palmoplantar hyperhidrosis - the usefulness of home therapy. Dermatologica 175, 126-135 (1987).
43. Miller, K. A., Balakrishnan, G., Eichbauer, G. & Betley, K. 1% lidocaine injection, EMLA cream, or 'numby stuff' for topical analgesia associated with peripheral intravenous cannulation. AANA J. 69, 185-187 (2001).
44. Tamada, J. et al. Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. JAMA 282, 1839-1844 (1999).
45. Ledger, P. W. Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Deliv. Rev. 9, 289-307 (1992).
46. Banga, A. K. Electrically-Assisted Transdermal and Topical Drug Delivery (Taylor & Francis, London, 1998).
47. Amsden, B. G. & Goosen, M. F. A. Transdermal delivery of peptide and protein drugs: an overview. AIChE J. 41, 1972-1997 (1995).
48. Pikal, M. J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 46, 281-305 (2001).
49. Higuchi, W. I., Li, S. K., Ghanem, A. H., Zhu, H. & Song, Y. Mechanistic aspects of iontophoresis in human epidermal membrane. J. Control. Release 62, 13-23 (1999).
50. Prausnitz, M. R. The effects of electric current applied to the skin: a review for transdermal drug delivery. Adv. Drug Deliv. Rev. 18, 395-425 (1996).
51. Chizmadzhev, Y. A. et al. Electrical properties of skin at moderate voltages: contribution of appendegeal macropores. Biophys. J. 74, 843-856 (1998).
52. Prausnitz, M. R., Bose, V. G., Langer, R. & Weaver, J. C. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl Acad. Sci. USA 90, 10504-10508 (1993).
53. Prausnitz, M. R. A practical assessment of transdermal drug delivery by skin electroporation. Adv. Drug Deliv. Rev. 35, 61-76 (1999).
54. Weaver, J. C., Vaughan, T. E. & Chizmadzhev, Y. Theory of electrical creation of aqueous pathways across skin transport barriers. Adv. Drug Deliv. Rev. 35, 21-40 (1999).
55. Prausnitz, M. R., Pliquett, U. & Vanbever, R. in Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery (eds Jaroszeski, M. J., Heller, R. & Gilbert, R.) 213-245 (Humana Press, Totowa, 2000).
56. Vanbever, R. & Preat, V. In vivo efficacy and safety of skin electroporation. Adv. Drug Deliv. Rev. 35, 77-88 (1999).
57. Wallace, M. S. et al. Topical delivery of lidocaine in healthy volunteers by electroporation, electroincorporation, or iontophoresis: an evaluation of skin anesthesia. Reg. Anesth. Pain Med. 26, 229-238 (2001).
58. Prausnitz, M. R., Edelman, E. R., Gimm, J. A., Langer, R. & Weaver, J. C. Transdermal delivery of heparin by skin electroporation. Bio/Technology 13, 1205-1209 (1995).
59. Sen, A., Daly, M. E. & Hui, S. W. Transdermal insulin delivery using lipid enhanced electroporation. Biochim. Biophys. Acta 1564, 5-8 (2002).
60. Misra, A., Ganga, S. & Upadhyay, P. Needle-free, non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus. Vaccine 18, 517-523 (1999).
61. Zewert, T. E., Pliquett, U. F., Langer, R. & Weaver, J. C. Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem. Biophys. Res. Com. 212, 286-292 (1995).
62. Zhang, L., Li, L., Hofmann, G. A. & Hoffman, R. M. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem. Biophys. Res. Comm. 220, 633-636 (1996).
63. Hofmann, G. A., Rustrum, W. V. & Suder, K. S. Electro-incorporation of microcarriers as a method for the transdermal delivery of large molecules. Bioelectrochem. Bioenerg. 38, 209-222 (1995).
64. Prausnitz, M. R., Pliquett, U., Langer, R. & Weaver, J. C. Rapid temporal control of transdermal drug delivery by electroporation. Pharm. Res. 11, 1834-1837 (1994).
65. Heller, R., Gilbert, R. & Jaroszeski, M. J. Clinical applications of electrochemotherapy. Adv. Drug Deliv. Rev. 35, 119-130 (1999).
66. Pliquett, U. Mechanistic studies of molecular transdermal transport due to skin electroporation. Adv. Drug Deliv. Rev. 35, 41-60 (1999).
67. Prausnitz, M. R. et al. Imaging of transport pathways across human stratum corneum during high-voltage and low-voltage electrical exposures. J. Pharm. Sci. 85, 1363-1370 (1996).
68. Fellinger, K. & Schmidt, J. Klinik and therapies des chromischen gelenkreumatismus. Maudrich Vienna, Austria 549-552 (1954).
69. Tyle, P. & Agrawala, P. Drug delivery by phonophoresis. Pharm. Res. 6, 355-361 (1989).
70. Merino, G., Kalia, Y. N. & Guy, R. H. Ultrasound-enhanced transdermal transport. J. Pharm. Sci. 92, 1125-1137 (2003).
71. Mitragotri, S., Blankschtein, D. & Langer, R. Ultrasound-mediated transdermal protein delivery. Science 269, 850-853 (1995).
72. Mitragotri, S. & Kost, J. Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm. Res. 18, 1151-1156 (2000).
73. Tachibana, K. Transdermal delivery of insulin to alloxan-diabetc rabits by ultrasound exposure. Pharm. Res. 9, 952-954 (1992).
74. Mitragotri, S. & Kost, J. Low-frequency sonophoresis: a non-invasive method for drug delivery and diagnostics. Biotech. Progress 16, 488-492 (2000).
75. Kost, J., Mitragotri, S., Gabbay, R., Pishko, M. & Langer, R. Transdermal extraction of glucose and other analytes using ultrasound. Nature Med. 6, 347-350 (2000).
76. Mitragotri, S., Edwards, D. A., Blankschtein, D. & Langer, R. A mechanistic study of ultrasonically enhanced transdermal drug delivery. J. Pharm. Sci. 84, 697-706 (1995).
77. Mitragotri, S., Blankschtein, D. & Langer, R. in Encyclopedia of Pharmaceutical Technology Vol. 14 (ed. Boylan, J.) 103-122 (Marcel Dekker, New York, 1996).
78. Menon, G. K., Kollias, N. & Doukas, A. G. Ultrastructural evidence of stratum corneum permeabilization induced by photomechanical waves. J. Invest. Dermatol. 121, 104-109 (2003).
79. Lee, S., McAuliffe, D. J., Mulholland, S. E. & Doukas, A. G. Photomechanical transdermal delivery of insulin in vivo. Lasers Surg. Med. 28, 282-285 (2001).
80. McAllister, D. V., Allen, M. G. & Prausnitz, M. R. Microfabricated microneedles for gene and drug delivery. Annu. Rev. Biomed. Eng. 2, 289-313 (2000).
81. Henry, S., McAllister, D., Allen, M. G. & Prausnitz, M. R. Microfabricated microneedles: a novel method to increase transdermal drug delivery. J. Pharm. Sci. 87, 922-925 (1998).
82. McAllister, D. V. et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Natl Acad. Sci. USA 100, 13755-13760 (2003).
83. Lin, W. et al. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm. Res. 18, 1789-1793 (2001).
84. Martanto, W. et al. Transdermal delivery of insulin using microneedles in vivo. Proc. Intl. Symp. Control. Rel. Bioact. Mater. A666 (2003).
85. Cormier, M. & Daddona, P. E. in Modified-Release Drug Delivery Technology (eds Rathbone, M. J., Hadgraft, J. & Roberts, M. S.) 589-598 (Marcel Dekker, Now York, 2003).
86. Matriano, J. A. et al. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm. Res. 19, 63-70 (2002).
87. Mikszta, J. A. et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nature Med. 8, 415-419 (2002).
88. Kaushik, S. et al. Lack of pain associated with microfabricated microneedles. Anesth. Analg. 92, 502-504 (2001).
89. Gerstel, M. S. & Place, V. A. Drug delivery device. US Patent 3,964,482 (1976).
90. Sintov, A. C. et al. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J. Control. Release 89, 311-320 (2003).
91. Bramson, J. et al. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther. 10, 251-260 (2003).
92. Gebhart, S. et al. Glucose sensing in transdermal body fluid collected under continuous vacuum pressure via micropores in the stratum corneum. Diabetes Technol. Ther. 5, 159-166 (2003).
93. Hingson, R. A. & Figge, F. H. A survey of the development of jet injection in parenteral therapy. Curr. Res. Anesth. Analg. 31, 361-366 (1952).
94. Bremseth, D. L. & Pass, F. Delivery of insulin by jet injection: recent observations. Diabetes Technol. Ther. 3, 225-232 (2001).
95. Burkoth, T. L. et al. Transdermal and transmucosal powdered drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 16, 331-384 (1999).
96. Mikkelsen Lynch, P. et al. A pharmacokinetic and tolerability evaluation of two continuous subcutaneous infusion systems compared to an oral controlled-release morphine. J. Pain Symptom Manage. 19, 348-356 (2000).
97. Mitragotri, S. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res. 17, 1354-1359 (2000).
98. Srinivasan, V., Su, M. H., Higuchi, W. I. & Behl, C. R. Iontophoresis of polypeptides: effect of ethanol pretreatment of human skin. J. Pharm. Sci. 79, 588-591 (1990).
99. Oh, S. Y., Jeong, S. Y., Park, T. G. & Lee, J. H. Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer. J. Control. Release 51, 161-168 (1998).
100. Wearley, L. & Chien, Y. W. Enhancement of the in vitro skin permeability of azidothymidine (AZT) via ontophoresis and chemical enhancers. Pharm. Res. 7, 34-40 (1990).
101. Ganga, S., Ramarao, J. & Singh, J. Effect of azone on the iontophoretic transdermal delivery of metoprolol tartarate through human epidermis in vitro. J. Control. Rel. 42, 57-64 (1996).
102. Bhatia, K. S., Gao, S. & Singh, J. Effetct of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability. J. Control. Rel. 47, 81-89 (1997).
103. Johnson, M. E., Mitragotri, S., Patel, A., Blankschtein, D. & Langer, R. Synergistic effect of ultrasound and chemical enhancers on transdermal drug delivery. J. Pharm. Sci. 85, 670-679 (1996).
104. Mitragotri, S. et al. Synergistic effect of ultrasound and sodium lauryl sulfate on transdermal drug delivery. J. Pharm. Sci. 89, 892-900 (2000).
105. Le, L., Kost, J. & Mitragotri, S. Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery. Pharm. Res. 17, 1151-1154 (2000).
106. Vanbever, R., Prausnitz, M. R. & Preat, V. Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm. Res. 14, 638-644 (1997).
107. Zewert, T. E., Pliquett, U. F., Vanbever, R., Langer, R. & Weaver, J. C. Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule. Bioelectrochem. Bioenerg. 49, 11-20 (1999).
108. Bommanon, D. B., Tamada, J., Leung, L. & Potts, R. O. Effects of electroporation on transdermal iontophoretic delivery of leutinizing hormone releasing hormone. Pharm. Res. 11, 1809-1814 (1994).
109. Benowitz, N. L. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N. Engl. J. Med. 319, 1318-1330 (1988).
110. Centers for Disease Control and Prevention. Cigarette smoking among adults - United States, 1988. MMWR Morb. Mortal. Wkly Rep. 40, 757-759,765 (1991).
111. Gora, M. L. Nicotine transdermal systems. Ann. Pharmacother 27, 742-750 (1993).
112. Cordoba-Diaz, M. et al. Validation protocol of an automated in-line flow-through diffusion equipment for in vitro permeation studies. J. Control. Release 69, 357-367 (2000).
113. Moody, R. P. Automated In Vitro Dermal Absorption (AIVDA): predicting skin permeation of atrazine with finite and infinite (swimming/bathing) exposure models. Toxicol. In Vitro 14, 467-474 (2000).
114. Karande, P. & Mitragotri, S. Dependence of skin permeability on contact area. Pharm. Res. 20, 257-263 (2003).
115. Cima, M., Chen, H. & Gyory, J. R. System and method for optimizing tissue barrier transfer of compounds. WO 02/06518 (2002).
116. Pritchard, J. F. et al. Making better drugs: decision gates in non-clinical drug development. Nature Rev. Drug Discov. 2, 542-553 (2003).
117. Leduc, S. Introduction of medicinal substances into the depth of tissues by electric current. Ann. d'Electrobiol. 3, 545-560 (1900).
118. Tachibana, K. & Tachibana, S. Transdermal delivery of insulin by ultrasonic vibration. J. Pharm. Pharmocol. 43, 270-271 (1991).
119. Lee, S., McAuliffe, D. J., Flotte, T. J., Kollias, N. & Doukas, A. G. Photomechanical transcutaneous delivery of macromolecules. J. Invest. Dermatol. 111, 925-929 (1998).